Morbus Adamantiades-Behçet – Ein klinischer Fallbericht

In der zahnärztlichen bzw. parodontologischen Praxis stellen sich Patienten mit den unterschiedlichsten Krankheitsbildern vor. Am Beispiel des Morbus Behçet wird gezeigt, dass grundsätzlich nicht nur die Lokalbehandlung der oralen Ulzera im Vordergrund stehen darf. Die Therapie der oralen Manifestationen beim Morbus Behçet sollte vor allem im Rahmen einer Interdisziplinärbehandlung erfolgen. Hierzu gehören u.a. auch eine professionelle Zahnreinigung und eine umfassende Parodontaltherapie sowie eine optimale Unterweisung und Motivation für die häusliche Zahnpflege. Die interdisziplinäre Zusammenarbeit, u.a. auch mit den Kollegen der Inneren Medizin, ist insgesamt für den Therapieerfolg von entscheidender Bedeutung.

In dental or periodontal surgery patients with different diseases introduce oneself. The example of Behcet's disease shows that, in principle, not only the local treatment of oral ulcers may stand in the foreground. The therapy of oral manifestations in Behcet's disease should be done especially in the context of an interdisciplinary treatment. These include a professional dental cleaning and a comprehensive periodontal therapy as well as optimal training and motivation for home care. The interdisciplinary cooperation, also with colleagues in internal medicine, is of crucial importance for the therapeutic success.

Schlüsselwörter

Morbus Behçet - orale Aphthen - Rheumatologie - Mundhygieneinstruktion - parodontale Therapieoption

Keywords

Behçet's Disease - Oral Aphthae - Rheumatology - Oral Hygiene Instruction - Periodontal Treatment Options

Literatur

• 1 Adamantiades B. A case of relapsing iritis with hypopion (in Greek). Archia Iatrikis Etairas.  Proceedings of the Medical Society of Athens. 1930;  586-539
• 2 Alpsoy E, Er H, Durusoy C et al.. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study.  Arch Dermatol. 1999;  135 529-532
• 3 Balogh A, Haen E. Klinische Pharmakologie in der zahnärztlichen Praxis. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2010. 213: 218
• 4 Bang D. Clinical spectrum of Behçet's disease.  Dermatol. 2001;  28 610-613
• 5 Bang D, Choi B, Kwon HJ et al.. Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model.  Eur J Pharmacol. 2008;  598 112-117
• 6 Baskan EB, Yilmaz E, Saricaoglu H et al.. Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease.  Clin Exp Dermatol. 2007;  32 186-190
• 7 Behcet H. Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien.  Dermatol Wschr. 1937;  105 1152-1157
• 8 Cobellis L, Pecori E, Rigatti F et al.. Therapeutic alternatives in Behçet's syndrome.  Clin Exp Obstet Gynecol. 2007;  34 151-153
• 9 Deuter CM, Kotter I, Gunaydin I et al.. Ocular involvement in Behcet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a.  Ophthalmologe. 2004;  101 129-134
• 10 Deutsche Gesellschaft für Autoimmunerkrankungen e.V. (DGfAE). Im Internet: http://www.autoimmun.org/erkrankungen/morbus-behcet.php Stand 2010
• 11 Elbirt D, Asher I, Sthoeger ZM. Behcet's disease - clinical presentation, diagnostic and therapeutic approach.  Harefuah. 2002;  141 497
• 12 Gul A. Standard and novel therapeutic approaches to Behcet's disease.  Drugs. 2007;  67 2013-2022
• 13 Hamuryudan V, Mat C, Saip S et al.. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.  Ann Intern Med. 1998;  128 443-450
• 14 Karacayli U, Mumcu G, Simsek I et al.. The close association between dental and periodontal treatments and oral ulcer course in behcet's disease: a prospective clinical study.  J Oral Pathol Med. 2009;  38 410-415
• 15 Kotter I, Gunaydin I, Stubiger N et al.. Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin.  Tissue Antigens. 2001;  58 166-170
• 16 Kotter I, Gunaydin I, Zierhut M et al.. The use of interferon alpha in Behcet disease: review of the literature.  Semin Arthritis Rheum. 2004;  33 320-335
• 17 Kotter I, Vonthein R, Gunaydin I et al.. Behçet's disease in patients of German and Turkish origin – a comparative study.  Adv Exp Med Biol. 2003;  528 53-58
• 18 Kotter I, Vonthein R, Zierhut M et al.. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behcet disease: results of an open 4-center trial.  Semin Arthritis Rheum. 2004;  33 311-319
• 19 Kotter I, Zierhut M, Eckstein A et al.. Human recombinant interferon-lpha2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis.  Br J Ophthalmol. 2003;  87 423-431
• 20 Lee E, Bang D, Lee S. Dermatologic manifestations of Behcet's disease.  Yonsei Med J. 1997;  38 380-389
• 21 Matsuda T, Ohno S, Hirohata S et al.. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.  Drugs R D. 2003;  4 19-28
• 22 Mendes D, Correia M, Barbedo M et al.. Behçet's disease – a contemporary review.  J Autoimmun. 2009;  32 178-188
• 23 Onder M, Gurer MA. The multiple faces of Behçet's disease and its aetiological factors.  J Eur Acad Dermatol Venereol. 2000;  15 126-136
• 24 Qin H, Cai J, Xu H et al.. Inhibition of Behcet's disease by calcitonin.  Med Hypotheses. 2009;  73 24-26
• 25 Sharquie KE, Najim RA, Abu-Raghif AR. Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.  J Dermatol. 2002;  29 267-279
• 26 Sohn S. Etiopathology of Behcet's disease: herpes simplex virus infection and animal model.  Yonsei Med J. 1997;  38 359-364
• 27 Störk S, Kneitz C, Bröcker E et al.. Morbus Adamantiades-Behcet Eine klinische Übersicht.  Medizinische Klinik. 2008;  103 143-152
• 28 Tojo M, Zheng X, Yanagihori H et al.. Detection of herpes virus genomes in skin lesions from patients with Behcet's disease and other related inflammatory diseases.  Acta Derm Venereol. 2003;  83 124-127
• 29 Tugal-Tutkun I, Onal S, Altan-Yaycioglu R et al.. Uveitis in Behçet disease: an analysis of 880 patients.  Am J Ophthalmol. 2004;  138 373-380
• 30 Yurdakul S, Mat C, Tüzün Y et al.. A double-blind trial of colchicine in Behçet's syndrome.  Arthritis Rheum. 2001;  44 2686-2692

Korrespondenzadresse